Determination of Residues and Safety Analysis of Metal Impurities in Platinum-based Antitumor Drugs

Juan PENG,Shaoping PU, Guangli LI,Jian HE, Zhirong ZHANG,Yunxing LIAO

Precious Metals(2012)

引用 0|浏览0
暂无评分
摘要
The residual metal impurities in cisplatin,carboplatin and oxaliplatin were determined by ICP-AES.The samples were ignited and dissolved with HC1:HNO3 (3:1).The method is simple and accurate.By the determination of the metal residues in the samples,the calculated actual daily exposure and concentration of the metal Pd,Ir,Rh,Ru,Mo,Ni,Cr,V,Cu,Mn,Fe and Zn that were less than the permitted daily exposures (PDE)and the limited concentration permitted in the EMEA guideline on the specification limits for residues of metal catalysts or metal reagents[1].The metal residues can de adequately removed from the active pharmaceutical ingredients and the corresponding drugs.The trace metal residues will not affect human health and lead to the safety hazard by the intravenous injection.
更多
查看译文
关键词
metal impurities,antitumor drugs,residues,platinum-based
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要